$CRDF
Cardiff Oncology, Inc. Stock $crdf

$crdf Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000162828018002226 Filed on February 26, 2018

Income Statement

Concept	2017 Q4	2017	2016 Q4
Revenue	$185.0K	$505.4K	$68.00K
YoY Change	172.06%	32.63%	-13.92%
Cost Of Revenue	$380.0K	$1.811M	$590.0K
YoY Change	-35.59%	4.68%	195.0%
Gross Profit	-$200.0K	-$1.306M	-$520.0K
YoY Change	-61.54%	-3.22%	333.33%
Gross Profit Margin	-108.11%	-258.41%	-764.71%
Selling, General & Admin	$1.850M	$14.23M	$3.610M
YoY Change	-48.75%	-38.12%	-13.01%
% of Gross Profit
Research & Development	$1.230M	$7.883M	$4.860M
YoY Change	-74.69%	-47.47%	56.27%
% of Gross Profit
Depreciation & Amortization	$290.0K	$1.248M	$380.0K
YoY Change	-23.68%	16.65%	192.31%
% of Gross Profit
Operating Expenses	$3.969M	$26.10M	$9.850M
YoY Change	-59.71%	-35.6%	31.98%
Operating Profit	-$4.169M	-$25.60M	-$10.37M
YoY Change	-59.8%	-36.24%	36.75%
Interest Expense	$1.380M	$1.034M	$1.380M
YoY Change	0.0%	-38.25%	13700.0%
% of Operating Profit
Other Income/Expense, Net	-$170.0K	-$170.0K	-$140.0K
YoY Change	21.43%	21.43%	1300.0%
Pretax Income	-$2.570M	-$24.91M	-$8.550M
YoY Change	-69.94%	-36.45%	15.85%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.570M	-$24.91M	-$8.550M
YoY Change	-69.94%	-36.47%	15.85%
Net Earnings / Revenue	-1389.19%	-4928.09%	-12573.53%
Basic Earnings Per Share	-$0.06	-$51.76	-$0.28
Diluted Earnings Per Share	-$0.06	-$51.76	-$0.34
COMMON SHARES
Basic Shares Outstanding	40.18M shares	481.7K shares	30.64M shares
Diluted Shares Outstanding	40.18M shares	481.7K shares	30.71M shares

Balance Sheet

Concept	2017 Q4	2017	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.200M	$8.200M	$37.90M
YoY Change	-78.36%	-78.36%	-43.85%
Cash & Equivalents	$8.226M	$8.200M	$13.92M
Short-Term Investments	$0.00	$0.00	$24.00M
Other Short-Term Assets	$1.200M	$1.200M	$1.000M
YoY Change	20.0%	20.0%	25.0%
Inventory
Prepaid Expenses
Receivables	$77.10K	$100.0K	$100.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.469M	$9.500M	$38.95M
YoY Change	-75.69%	-75.64%	-43.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.426M	$2.400M	$3.827M
YoY Change	-36.6%	-36.84%	42.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$389.9K	$400.0K	$1.173M
YoY Change	-66.77%	-66.67%	213.71%
Total Long-Term Assets	$2.816M	$2.800M	$5.000M
YoY Change	-43.68%	-44.0%	63.16%
TOTAL ASSETS
Total Short-Term Assets	$9.469M	$9.500M	$38.95M
Total Long-Term Assets	$2.816M	$2.800M	$5.000M
Total Assets	$12.28M	$12.30M	$43.95M
YoY Change	-72.05%	-72.05%	-38.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$825.2K	$800.0K	$1.131M
YoY Change	-27.0%	-27.27%	8.61%
Accrued Expenses	$1.455M	$1.500M	$4.021M
YoY Change	-63.83%	-62.5%	111.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.300M	$1.300M	$2.400M
YoY Change	-45.83%	-45.83%	-53.85%
Total Short-Term Liabilities	$3.946M	$3.900M	$7.797M
YoY Change	-49.4%	-50.0%	-4.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$14.20M
YoY Change	-100.0%	-100.0%	26.79%
Other Long-Term Liabilities	$1.800M	$1.800M	$2.200M
YoY Change	-18.18%	-18.18%
Total Long-Term Liabilities	$1.800M	$1.800M	$16.40M
YoY Change	-89.02%	-89.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.946M	$3.900M	$7.797M
Total Long-Term Liabilities	$1.800M	$1.800M	$16.40M
Total Liabilities	$5.779M	$5.800M	$24.18M
YoY Change	-76.1%	-76.03%	6.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$173.0M		-$148.1M
YoY Change	16.83%		36.03%
Common Stock	$5.279K		$3.070K
YoY Change	71.95%		3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.506M	$6.500M	$19.77M
YoY Change
Total Liabilities & Shareholders Equity	$12.28M	$12.30M	$43.95M
YoY Change	-72.05%	-72.05%	-38.48%

Cashflow Statement

Concept	2017 Q4	2017	2016 Q4
OPERATING ACTIVITIES
Net Income	-$2.570M	-$24.91M	-$8.550M
YoY Change	-69.94%	-36.47%	15.85%
Depreciation, Depletion And Amortization	$290.0K	$1.248M	$380.0K
YoY Change	-23.68%	16.65%	192.31%
Cash From Operating Activities	-$3.330M	-$23.28M	-$9.000M
YoY Change	-63.0%	-25.0%	32.16%
INVESTING ACTIVITIES
Capital Expenditures	$40.00K	$101.1K	-$20.00K
YoY Change	-300.0%	-87.72%	-97.96%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$24.06M	$440.0K
YoY Change	-100.0%	-200.21%	4300.0%
Cash From Investing Activities	$30.00K	$23.96M	$420.0K
YoY Change	-92.86%	-196.5%	-143.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$11.73M
YoY Change		395.9%
Debt Paid & Issued, Net		$15.00M
YoY Change		68.61%
Cash From Financing Activities	4.070M	-6.380M	-60.00K
YoY Change	-6883.33%	-377.39%	-105.31%
NET CHANGE
Cash From Operating Activities	-3.330M	-23.28M	-9.000M
Cash From Investing Activities	30.00K	23.96M	420.0K
Cash From Financing Activities	4.070M	-6.380M	-60.00K
Net Change In Cash	770.0K	-5.700M	-8.640M
YoY Change	-108.91%	-89.36%	29.92%
FREE CASH FLOW
Cash From Operating Activities	-$3.330M	-$23.28M	-$9.000M
Capital Expenditures	$40.00K	$101.1K	-$20.00K
Free Cash Flow	-$3.370M	-$23.38M	-$8.980M
YoY Change	-62.47%	-26.62%	54.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001213037
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55290162	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	38261592	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Trovagene, Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q4	trov	Accruedresearchagreements Accruedresearchagreements	736199	USD
CY2017Q4	trov	Accruedresearchagreements Accruedresearchagreements	135139	USD
CY2016	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	-2321053	USD
CY2017	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	0	USD
CY2016	trov	Adjustments To Additional Paid In Capital Warrant Issued Debt Agreement AdjustmentsToAdditionalPaidInCapitalWarrantIssuedDebtAgreement	148885	USD
CY2016	trov	Amortized Portion Of Final Fee Upon Repayment AmortizedPortionOfFinalFeeUponRepayment	390548	USD
CY2017	trov	Amortized Portion Of Final Fee Upon Repayment AmortizedPortionOfFinalFeeUponRepayment	293614	USD
CY2015Q2	trov	Area Of Land After Expansion AreaOfLandAfterExpansion	26100	sqft
CY2015Q4	trov	Area Of Land After Expansion AreaOfLandAfterExpansion	2300	sqft
CY2016	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	8333	shares
CY2016	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	50000	shares
CY2017	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	1910674	shares
CY2016	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	30992	shares
CY2017	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	19643626	shares
CY2015Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.86
CY2016Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.83
CY2017Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	0.95
CY2016	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.00
CY2016	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	8.00
CY2017	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	5.32
CY2016	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	4.84
CY2017	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	0.56
CY2016	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-39214492	USD
CY2017	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-24895971	USD
CY2016Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	2817000	USD
CY2017Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	3084000	USD
CY2017	trov	Defined Contribution Plan Threshold Age Catch Up Contribution DefinedContributionPlanThresholdAgeCatchUpContribution	P50Y
CY2016	trov	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	0.00
CY2017	trov	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	0.03
CY2016	trov	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	-114000	USD
CY2017	trov	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	-706000	USD
CY2016	trov	Leaseholdimprovementspaidforbylessor Leaseholdimprovementspaidforbylessor	1860000	USD
CY2017	trov	Leaseholdimprovementspaidforbylessor Leaseholdimprovementspaidforbylessor	0	USD
CY2015Q2	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	68000	USD
CY2015Q4	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	3100	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Net Next Twelve Months OperatingLeasesFutureMinimumPaymentsDueNetNextTwelveMonths	665311	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Net Thereafter OperatingLeasesFutureMinimumPaymentsDueNetThereafter	0	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Net Total OperatingLeasesFutureMinimumPaymentsDueNetTotal	3279924	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Netin Five Years OperatingLeasesFutureMinimumPaymentsDueNetinFiveYears	0	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Netin Four Years OperatingLeasesFutureMinimumPaymentsDueNetinFourYears	959401	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Netin Three Years OperatingLeasesFutureMinimumPaymentsDueNetinThreeYears	931457	USD
CY2017Q4	trov	Operating Leases Future Minimum Payments Due Netin Two Years OperatingLeasesFutureMinimumPaymentsDueNetinTwoYears	723755	USD
CY2016Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	148885	USD
CY2017Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	0	USD
CY2016	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	24240	USD
CY2017	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	24240	USD
CY2016	trov	Stock Issued During Period Value Warrants Exercised Net StockIssuedDuringPeriodValueWarrantsExercisedNet	0	USD
CY2017	trov	Warrants Classified As Derivative Liabilities Value WarrantsClassifiedAsDerivativeLiabilitiesValue	3215519	USD
CY2015	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P2Y6M11D
CY2016	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P1Y7M6D
CY2017	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P4Y4M21D
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1130536	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	825244	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	100460	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	77095	USD
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-107261	USD
CY2017	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-9230	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4021365	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1454587	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	421314	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1761985	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2071492	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10773	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167890984	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	179546954	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7504316	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4012585	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7504316	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4012585	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	173803	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	113780	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10402359	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29383422	shares
CY2016Q4	us-gaap	Assets Assets	43950411	USD
CY2017Q4	us-gaap	Assets Assets	12284941	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	38950192	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	9468687	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	374	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9439	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	23987087	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	6400	USD
CY2016	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2017	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-6400	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67493047	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13915094	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8225764	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5533242	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5505901	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	23238853	shares
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30696791	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52791584	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30696791	shares
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16592000	USD
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52791584	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	3070	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	5279	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39238732	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24920211	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	1730512	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	1811424	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-14035000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	9781000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-114000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12952000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	285246	USD
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	334424	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1373717	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1183677	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2443000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3171000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	50260000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	37307000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41502000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29713000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1283000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	945000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4658000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3565000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16592000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-12953000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	50260000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	37307000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2016	us-gaap	Depreciation Depreciation	969833	USD
CY2017	us-gaap	Depreciation Depreciation	1053913	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1069547	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1247576	USD
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	834940	USD
CY2017Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	649387	USD
CY2016	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24240	USD
CY2017	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24240	USD
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.37
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.30
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5825	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	7569	USD
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.43
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.43
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.85
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.00
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.00
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.03
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.02
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2203876	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	618128	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-577314	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-455051	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1655825	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11475947	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11497466	USD
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	104700	USD
CY2017	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16996000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-23281067	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	800	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2157221	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2940999	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1724	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23365	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-11029000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	21454000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-114000	USD
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-13206000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8591000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2286000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-697000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1276000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	431000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	4560	USD
CY2016	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	84182	USD
CY2017	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	90330	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	201037	USD
CY2017	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	140863	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	789739	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	277327	USD
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	208185	USD
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	106425	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016	us-gaap	Interest Expense InterestExpense	1674341	USD
CY2017	us-gaap	Interest Expense InterestExpense	1033939	USD
CY2016	us-gaap	Interest Paid InterestPaid	1103677	USD
CY2017	us-gaap	Interest Paid InterestPaid	668465	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	298829	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	147883	USD
CY2016Q4	us-gaap	Liabilities Liabilities	24182272	USD
CY2017Q4	us-gaap	Liabilities Liabilities	5778834	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43950411	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12284941	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7797256	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3945770	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1331515	USD
CY2017Q4	us-gaap	Litigation Reserve LitigationReserve	2100000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14176359	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	0	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2360109	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1331515	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-53577953	USD
CY2017	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-5689330	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2301376	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-6378057	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-24833649	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	23962225	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31039855	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-39203719	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-24906744	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10269000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10208000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10197000	USD
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8554000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39227959	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10005000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8052000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4298000	USD
CY2017Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2576000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24930984	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-41549012	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24930984	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	10579000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	10084000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	10013000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	9850000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	40526683	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	10221000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	5990000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	5921000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	3969000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	26101201	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-40145611	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-25595797	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3679552	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	881815	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	959401	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	931457	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	906879	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	399628	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	216504	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	0	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	0	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	0	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	183124	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	0	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	602000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	663000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	659976	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	701320	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1173304	USD
CY2016	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	36873	USD
CY2017	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	23849	USD
CY2016	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2017	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1613067	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	79386	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	866039	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	37760166	USD
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	8804604	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	389942	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1708	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1708	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10773	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10773	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-9065	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9065	USD
CY2016	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-144733	USD
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-170138	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	823483	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101101	USD
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	24240	USD
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	24240	USD
CY2016Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2017Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	956616	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1165828	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2364801	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11727153	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7805085	USD
CY2017	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2017	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	100000	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	792251	USD
CY2017	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	13750000	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	16431837	USD
CY2016	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	16434553	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1540	USD
CY2016	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	USD
CY2017	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	589700	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	262000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148115202	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-173046186	USD
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	626104	USD
CY2016	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	15006642	USD
CY2017	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7882650	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	790438	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	2174251	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	366966	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5588900	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4497804	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3826915	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2426312	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8896166	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15000000	USD
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	52175	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	258062	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	285444	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	120000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	104000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	89000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	68000	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	381072	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	95000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	102000	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	123000	USD
CY2017Q4	us-gaap	Sales Revenue Net SalesRevenueNet	185000	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	505404	USD
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	86137	USD
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	196111	USD
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11523144	USD
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2735410	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	7504316	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	4012585	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1932799	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	293781	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	647885	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6261655	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3992127	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	23978022	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2017	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	745392	shares
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2285415	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10861113	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	366966	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	48701289	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	19768139	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	6506107	USD
CY2016	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2462137	USD
CY2017	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	3401072	USD
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30108377	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29958037	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30339774	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30711946	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30281263	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30961014	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30991740	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36465672	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40182071	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34680362	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29755184	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29958037	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30339774	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30639440	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30174838	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30961014	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30991740	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36465672	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40182071	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34680362	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and short-term investments. The Company maintains deposit accounts at financial institutions that are in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash due to the financial position of the depository institution in which those deposits are held. We limit our exposure to credit loss by generally placing our cash and short-term investments in high credit quality financial institutions and investment in fixed income instruments denominated and payable in U.S. dollars. Additionally, we have established guidelines regarding diversification of our investments and their maturities, which are designed to maintain principal and maximize liquidity.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-002226-index-headers.html	Edgar Link	pending
0001628280-18-002226-index.html	Edgar Link	pending
0001628280-18-002226.txt	Edgar Link	pending
0001628280-18-002226-xbrl.zip	Edgar Link	pending
exhibit231q42017.htm	Edgar Link	pending
exhibit311q42017.htm	Edgar Link	pending
exhibit321q42017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trov-123117x10k.htm	Edgar Link	pending
trov-20171231.xml	Edgar Link	completed
trov-20171231.xsd	Edgar Link	pending
trov-20171231_cal.xml	Edgar Link	unprocessable
trov-20171231_def.xml	Edgar Link	unprocessable
trov-20171231_lab.xml	Edgar Link	unprocessable
trov-20171231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRDF
Cardiff Oncology, Inc. Stock $crdf

2017 Q4 Form 10-K Financial Statement

#000162828018002226 Filed on February 26, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF Cardiff Oncology, Inc. Stock $crdf

2017 Q4 Form 10-K Financial Statement

#000162828018002226 Filed on February 26, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF
Cardiff Oncology, Inc. Stock $crdf